YOU ARE NOW SUBSCRIBED TO MEDTECH HORIZON
Structured Regulatory Intelligence for MedTech Leaders
Your Welcome Edition is on its way
This will introduce how we approach MDR and IVDR interpretation in practice, focusing on what withstands scrutiny, not just what satisfies documentation requirements.
MedTech Horizon extends the structured regulatory analysis published across our work.
Each issue is developed by specialists working directly on:
Clinical Evaluation
Performance Evaluation
Post-Market Systems & Lifecycle Strategy
Risk Management
Biological Evaluation
Regulatory Strategy & Market Access
Notified Body Interactions
You will receive one issue per month:
No promotional updates
No generic summaries
Only practical interpretation of regulatory expectations, grounded in real submissions
What “ready” means in practice
Across MDR and IVDR, the primary challenge is rarely the absence of documentation.
It is the absence of structural clarity.
Regulatory systems are no longer assessed as static outputs, but rather they are evaluated as defensible, connected frameworks.
The distinction is subtle but it can have significant impact on how MedTech professionals and leaders work:
A compliant document may meet formal requirements, but
A regulatory-ready system withstands independent scrutiny
This is where most teams encounter avoidable exposure.
Need clarity on your current position?
A structured, expert-led discussion aligned to your device, evidence strategy, and regulatory pathway.
If you are preparing for submission, updating technical documentation, or responding to regulatory feedback, a focused review can help clarify where you stand—and where risk may exist.
Prefer to explore further first?
» Explore our regulatory support
What to Expect Next
Each issue of MedTech Horizon follows a consistent structure:
Regulatory Signals
Where expectations are shifting.
Structured Insights
Where regulatory teams commonly encounter exposure.
Practical Application
How to translate expectation into defensible documentation.